Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Tempest Therapeutics stock

Learn how to easily invest in Tempest Therapeutics stock.

Tempest Therapeutics Inc is a biotechnology business based in the US. Tempest Therapeutics shares (TPST) are listed on the NASDAQ and all prices are listed in US Dollars. Tempest Therapeutics employs 14 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Tempest Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TPST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Tempest Therapeutics stock price (NASDAQ: TPST)

Use our graph to track the performance of TPST stocks over time.

Tempest Therapeutics shares at a glance

Information last updated 2022-01-22.
Latest market close$3.84
52-week range$3.55 - $41.55
50-day moving average $7.47
200-day moving average $13.54
Wall St. target price$37.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-9.29

Buy Tempest Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Stocks
$0
0%
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$0
$1 per month
$5
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Public
Stocks, ETFs, Cryptocurrency
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tempest Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tempest Therapeutics price performance over time

Historical closes compared with the close of $3.841 from 2022-01-25

1 week (2022-01-20) 1.08%
1 month (2021-12-27) -34.23%
3 months (2021-10-27) -66.57%
6 months (2021-07-27) -75.71%
1 year (2021-01-27) 106.51%
2 years (2020-01-27) -52.23%
3 years (2019-01-25) 10.045
5 years (2017-01-27) 143.10%

Tempest Therapeutics financials

Gross profit TTM $0
Return on assets TTM -79.27%
Return on equity TTM -196.78%
Profit margin 0%
Book value $6.31
Market capitalisation $25.2 million

TTM: trailing 12 months

Tempest Therapeutics share dividends

We're not expecting Tempest Therapeutics to pay a dividend over the next 12 months.

Have Tempest Therapeutics's shares ever split?

Tempest Therapeutics's shares were split on a 1:15 basis on 27 June 2021. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tempest Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Tempest Therapeutics shares which in turn could have impacted Tempest Therapeutics's share price.

Tempest Therapeutics overview

Tempest Therapeutics Inc. , a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha, and is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company is headquartered in South San Francisco, California. .

Frequently asked questions

What percentage of Tempest Therapeutics is owned by insiders or institutions?
Currently 1.315% of Tempest Therapeutics shares are held by insiders and 39.492% by institutions.
How many people work for Tempest Therapeutics?
Latest data suggests 14 work at Tempest Therapeutics.
When does the fiscal year end for Tempest Therapeutics?
Tempest Therapeutics's fiscal year ends in December.
Where is Tempest Therapeutics based?
Tempest Therapeutics's address is: 7000 Shoreline Court, South San Francisco, CA, United States, 94080
What is Tempest Therapeutics's ISIN number?
Tempest Therapeutics's international securities identification number is: US87978U1088

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site